These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 18399875)
41. Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis. Kik SV; Franken WP; Arend SM; Mensen M; Cobelens FG; Kamphorst M; van Dissel JT; Borgdorff MW; Verver S Int J Tuberc Lung Dis; 2009 Jul; 13(7):820-8. PubMed ID: 19555530 [TBL] [Abstract][Full Text] [Related]
42. [Possible presence of a booster effect in people repeatedly exposed to Mycobacterium tuberculosis demonstrated in a Mycobacterium tuberculosis-specific interferon-gamma release assay]. Yoshikawa H Kekkaku; 2012 Sep; 87(9):557-64. PubMed ID: 23198601 [TBL] [Abstract][Full Text] [Related]
43. Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. Igari H; Watanabe A; Sato T Int J Tuberc Lung Dis; 2007 Jul; 11(7):788-91. PubMed ID: 17609055 [TBL] [Abstract][Full Text] [Related]
44. The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in Bacille Calmette-Guérin vaccinated children. Chun JK; Kim CK; Kim HS; Jung GY; Lee TJ; Kim KH; Kim DS Diagn Microbiol Infect Dis; 2008 Dec; 62(4):389-94. PubMed ID: 18990532 [TBL] [Abstract][Full Text] [Related]
45. [Usefulness of a whole blood interferon gamma assay (QuantiFERON-TB-2G) for detecting tuberculosis infection in HIV-infected persons]. Nagai H; Kawabe Y; Ariga H; Shigiyama F; Shimada M; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ooshima N; Masuda K; Matsui H; Tamura A; Nagayama N; Akagawa S; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2007 Aug; 82(8):635-40. PubMed ID: 17874571 [TBL] [Abstract][Full Text] [Related]
46. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study. Johnson JL; Geldenhuys H; Thiel BA; Toefy A; Suliman S; Pienaar B; Chheng P; Scriba T; Boom WH; Hanekom W; Hatherill M Chest; 2014 Mar; 145(3):612-7. PubMed ID: 24135768 [TBL] [Abstract][Full Text] [Related]
48. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Aichelburg MC; Rieger A; Breitenecker F; Pfistershammer K; Tittes J; Eltz S; Aichelburg AC; Stingl G; Makristathis A; Kohrgruber N Clin Infect Dis; 2009 Apr; 48(7):954-62. PubMed ID: 19245343 [TBL] [Abstract][Full Text] [Related]
49. Contact investigation in a primary school using a whole blood interferon-gamma assay. Higuchi K; Kondo S; Wada M; Hayashi S; Ootsuka G; Sakamoto N; Harada N J Infect; 2009 May; 58(5):352-7. PubMed ID: 19342102 [TBL] [Abstract][Full Text] [Related]
50. Whole-blood interferon-gamma assay for the diagnosis of tuberculosis infection in an unselected Greek population. Gerogianni I; Papala M; Klapsa D; Zinzaras E; Petinaki E; Gourgoulianis KI Respirology; 2008 Mar; 13(2):270-4. PubMed ID: 18339027 [TBL] [Abstract][Full Text] [Related]
51. Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis? Bosshard V; Roux-Lombard P; Perneger T; Metzger M; Vivien R; Rochat T; Janssens JP Respir Med; 2009 Jan; 103(1):30-4. PubMed ID: 18977647 [TBL] [Abstract][Full Text] [Related]
52. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Ferrand RA; Bothamley GH; Whelan A; Dockrell HM Int J Tuberc Lung Dis; 2005 Sep; 9(9):1034-9. PubMed ID: 16158897 [TBL] [Abstract][Full Text] [Related]
53. Changes in the levels of interferon-gamma and transforming growth factor-beta influence bronchial stenosis during the treatment of endobronchial tuberculosis. Kim Y; Kim K; Joe J; Park H; Lee M; Kim Y; Choi Y; Park S Respiration; 2007; 74(2):202-7. PubMed ID: 17124378 [TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815 [TBL] [Abstract][Full Text] [Related]
55. Waning of the specific interferon-gamma response after years of tuberculosis infection. Mori T; Harada N; Higuchi K; Sekiya Y; Uchimura K; Shimao T Int J Tuberc Lung Dis; 2007 Sep; 11(9):1021-5. PubMed ID: 17705982 [TBL] [Abstract][Full Text] [Related]
56. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Diel R; Schaberg T; Loddenkemper R; Welte T; Nienhaus A Respir Med; 2009 Dec; 103(12):1838-53. PubMed ID: 19682884 [TBL] [Abstract][Full Text] [Related]
57. Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis. Kim CH; Choi KJ; Yoo SS; Lee SY; Won DI; Lim JO; Cha SI; Park JY; Lee J Cytometry B Clin Cytom; 2014 Jul; 86(4):236-43. PubMed ID: 23959689 [TBL] [Abstract][Full Text] [Related]
58. Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy. Takayanagi K; Aoki M; Aman K; Mitarai S; Harada N; Higuchi K; Okumura M; Yoshiyama T; Ogata H; Mori T Jpn J Infect Dis; 2011; 64(2):133-8. PubMed ID: 21519127 [TBL] [Abstract][Full Text] [Related]
59. Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis. Song KH; Jeon JH; Park WB; Kim SH; Park KU; Kim NJ; Oh MD; Kim HB; Choe KW Diagn Microbiol Infect Dis; 2009 Feb; 63(2):182-7. PubMed ID: 19070449 [TBL] [Abstract][Full Text] [Related]